{"pub_date": "2016-03-08T00:00:00Z", "subsection_name": null, "lead_paragraph": "Preventing infections through vaccination or public health measures is the outcome to aim for.", "print_page": "3", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "CARROLL", "firstname": "Aaron", "role": "reported", "middlename": "E."}], "original": "By AARON E. CARROLL"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 400, "url": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-articleLarge.gif", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-articleLarge.gif"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "The Upshot", "headline": {"content_kicker": "The New Health Care", "print_headline": "Antibiotic Resistance Is Worrisome, but Not Hopeless", "main": "We\u2019re Losing the Race Against Antibiotic Resistance, but There\u2019s Also Reason for Hope", "kicker": "The Upshot"}, "source": "The New York Times", "blog": [], "word_count": "1178", "web_url": "http://www.nytimes.com/2016/03/08/upshot/were-losing-the-race-against-antibiotic-resistance-but-theres-also-reason-for-hope.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Preventing infections through vaccination or public health measures is the outcome to aim for.", "_id": "56dd6b2b38f0d874be467d01", "abstract": "The Upshot; growing resistance to antibiotics could be countered with development of new ones, but relatively low profits for drug companies have slowed innovation; several programs to incentivize new antibiotic drug development, including money for research, discussed.", "keywords": [{"rank": "1", "name": "subject", "value": "Antibiotics", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "3", "name": "subject", "value": "Bacteria", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "Preventive Medicine", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Livestock Diseases", "is_major": "N"}, {"rank": "6", "name": "subject", "value": "Methicillin-Resistant Staphylococcus Aureus", "is_major": "N"}, {"rank": "7", "name": "subject", "value": "E Coli (Bacteria)", "is_major": "N"}, {"rank": "8", "name": "subject", "value": "Epidemics", "is_major": "N"}]}